EGFR and leukemia: Axl in particular has been shown to mediate the resistance of solid tumors and leukemias to epidermal growth factor receptor (EGFR)-directed chemotherapeutic agents (Hong et al., 2008; Zhang et al., 2012; Meyer et al., 2013).